10.1001/jama.2017.18391 JAMA
N Engl J Med 381:19952008 Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Bhm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F (2020) EMPEROR-Reduced Trial Investigators
Recalls & Warnings July 17, 2023 Seller of Ashwagandha, Lions Mane & Other Supplements Warned for Manufacturing Violations On March 17, 2023, the FDA issued a warning letter to Brand Packaging Group, Inc
Intranasal administration of the GHRP hexarelin accelerates growth in short children
Acknowledgements Authors are thankful to the DST INSPIRE, Govt